Melissa Case Study

MelissaCase Study

MelissaCase Study

Patient Personal and Medical History, Drug Therapy, Treatment andFollow-up Care

Melissa is a 32-year-old African-American in her second pregnancy.She has had one live birth and did not have a history of abortions.She is seen for prenatal care at 23 weeks gestation. She weighs 225lb, and her blood pressure is 129/80 mmHg. The measurement of heruterine size reflects that it is appropriate for the gestational age.Further, previous obstetric history states a vaginal delivery of a10lb, 7 oz female infant during the 40th week ofgestation. Melissa has gestational diabetes and is currently ondietary and insulin therapy to help remedy the situation. She takesoral antidiabetic drugs to help in dealing with the situation. She isself-monitoring herself for blood glucose and conducts tests whilefasting to check for sugar levels. Melissa comes to the clinic everyweek for follow-up care.

Implicationsof Patients Health Problem

Gestational diabetes can result in an increase in the overall bloodsugar leading to complications for the pregnant woman and the unbornchild (Nielsen et al., 2014). Melissa is at risk of experiencingexcessive birth weight. The excess glucose in the blood could crossthe placenta, triggering the baby’s pancreas produce insulin thatcould lead to it growing too large. Further, Melissa is at risk ofexperiencing early birth, especially if it is determined that thebaby is too large. A possible implication for Melissa if thesituation is not addressed in time is the development of high bloodpressure that could be life-threatening.

Reflectionon Health Problem

The Centers for Disease Control identify the need for access theNational Diabetes Prevention Program (Centers for Disease Control andPrevention, 2012b). Through the program, it could help Melissa changeher lifestyle to manage type 2 diabetes. Periodic assessments areessential in helping Melissa monitor her condition effectively.Further, the CDC identifies preventive measures as being appropriateto help in dealing with the condition as poor management results infurther complications (Centers for Disease Control and Prevention,2011).


Centers for Disease Control and Prevention. (2011). During pregnancy.Retrieved from

Centers for Disease Control and Prevention. (2012b). Women’shealth. Retrieved from

Nielsen, K. K., Kapur, A., Damm, P., De Courten, M., &amp Bygbjerg,I. C. (2014). From screening to postpartum follow-up–thedeterminants and barriers for gestational diabetes mellitus (GDM)services, a systematic review. BMC pregnancy and childbirth,14(1), 1.